Analyst consensus rating
GE HealthCare Technologies Analyst Rating: Buy
Direct answer
GE HealthCare Technologies's consensus rating is Buy.
18 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $82.50.
Forecast evidence checked September 7, 2026.
Get free GE HealthCare Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $68.86
- Average price target
- $82.50
- High price target
- $96.00
- Low price target
- $70.00
- Low target gap
- +1.7%
- Target upside
- +19.8%
- High target gap
- +39.4%
- Target range width
- 37.8%
- Consensus rating
- Buy
- Analysts
- 18
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for GE HealthCare Technologies?
GE HealthCare Technologies has a verified Buy consensus. The same dataset has an average price target of $82.50.
How far are GE HealthCare Technologies's low and high targets from the recorded price?
The low target implies +1.7%, while the high target implies +39.4%.
How many analysts are included in GE HealthCare Technologies's consensus?
The verified consensus includes 18 analysts.
How is GE HealthCare Technologies's target upside or downside calculated?
The average target of $82.50 is divided by the recorded price of $68.86, then one is subtracted to produce +19.8%. This does not guarantee a future return.
When was GE HealthCare Technologies's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.